Ethyl levulinate is a colorless liquid with a pleasant odor. It is a promising bio-based platform chemical derived from biomass sources like lignocellulose. Synthesis typically involves the reaction of levulinic acid with ethanol, catalyzed by acidic or enzymatic methods. Ethyl levulinate exhibits various potential applications: as a biofuel additive, a solvent for pharmaceuticals, a precursor for polymers, and a component in fragrances. Research on ethyl levulinate focuses on optimizing its production methods, exploring its versatility as a renewable chemical, and evaluating its potential for biofuel development and other green technologies. Its high biodegradability and low toxicity make it a sustainable alternative to traditional petroleum-based chemicals.'
ethyl levulinate: structure in first source
ID Source | ID |
---|---|
PubMed CID | 10883 |
CHEMBL ID | 3182933 |
CHEBI ID | 169371 |
SCHEMBL ID | 92709 |
MeSH ID | M0538026 |
Synonym |
---|
4-03-00-01562 (beilstein handbook reference) |
7bu24css2g , |
unii-7bu24css2g |
CHEBI:169371 |
pentanoic acid, 4-oxo-, ethyl ester |
nsc-24876 |
nsc24876 |
ethyl acetylpropanoate |
fema no. 2442 |
ai3-00677 |
brn 0507641 |
ethyl ketovalerate |
ethyl levulinate (natural) |
einecs 208-728-2 |
nsc 24876 |
nsc-8863 |
ethyl 4-oxovalerate |
ethyl 3-acetylpropionate |
ethyl laevulinate |
ethyl levulinate |
ethyl levulate |
ethyl 4-ketovalerate |
539-88-8 |
levulinic acid, ethyl ester |
ethyl 4-oxopentanoate |
nsc8863 |
ethyl levulinate, 99% |
gmeonfutdyjsnv-uhfffaoysa- |
inchi=1/c7h12o3/c1-3-10-7(9)5-4-6(2)8/h3-5h2,1-2h3 |
4-oxovaleric acid ethyl ester |
4-ketovaleric acid ethyl ester |
levulinic acid ethyl ester |
3-acetylpropionic acid ethyl ester |
L0120 |
4-oxo-pentanoic acid ethyl ester |
ethyl-4-oxovalerate |
NCGC00256288-01 |
cas-539-88-8 |
dtxcid6027058 |
dtxsid8047058 , |
tox21_302292 |
ethyl 4-oxidanylidenepentanoate |
A829891 |
4-oxopentanoic acid ethyl ester |
BBL009708 |
AKOS005716867 |
STL141073 |
FT-0625785 |
ethyl levulinate [fhfi] |
ethyl levulinate [fcc] |
ethyl levulinate [mi] |
SCHEMBL92709 |
ethyllevulinate |
W-105687 |
CHEMBL3182933 |
F0001-1401 |
mfcd00009209 |
ethyl levulinate, natural, >=98%, fg |
ethyl levulinate, >=98%, fcc, fg |
fema 2442 |
CS-W011009 |
DS-4184 |
CS-0204023 |
BCP30245 |
D77713 |
bkq , |
Q27268032 |
EN300-59517 |
ethyl4-oxopentanoate |
The toxicity of levulinate esters in aquatic exposure (assessed as the EC50) increased as a function of increasing alkyl chain length. The most toxic compound for the aquatic organisms was butyl Levulinate, followed by ethyllevulinate and methyl levulinates.
Excerpt | Reference | Relevance |
---|---|---|
" As a general trend, the toxicity of levulinate esters in aquatic exposure (assessed as the EC50) increased as a function of increasing alkyl chain length; accordingly, the most toxic compound for the aquatic organisms was butyl levulinate, followed by ethyl levulinate and methyl levulinate." | ( Ecotoxicity studies of the levulinate ester series. Giner, B; Lomba, L; Muñiz, S; Navarro, E; Pino, MR, 2014) | 0.58 |
" In this study, the three potential biofuels ethyl levulinate (EL), 2-methyltetrahydrofuran (2-MTHF) and 2-methylfuran (2-MF) were investigated for their acute embryo toxicity and teratogenicity using the fish embryo toxicity (FET) test to identify unknown hazard potentials and to allow focusing further research on substances with low toxic potentials." | ( Acute embryo toxicity and teratogenicity of three potential biofuels also used as flavor or solvent. Anders, N; Bluhm, K; Hollert, H; Klankermayer, J; Schaeffer, A; Seiler, TB, 2016) | 0.69 |
" 2-MF revealed the highest toxic potential with significant induction of micronuclei below 20." | ( Genotoxicity of three biofuel candidates compared to reference fuels. Anders, N; Bluhm, K; Brendt, J; Heger, S; Hollert, H; Mayer, P; Redelstein, R; Schaeffer, A, 2018) | 0.48 |
Excerpt | Relevance | Reference |
---|---|---|
" In this study, we evaluated the acute ecotoxicity of four levulinates (levulinic acid, methyl levulinate, ethyl levulinate and butyl levulinate) on freshwater algae (Chlamydomonas reinhardtii), bacteria (Vibrio fischeri), daphnids (Daphnia magna) and earthworms (Eisenia foetida) using various dose-response tests." | ( Ecotoxicity studies of the levulinate ester series. Giner, B; Lomba, L; Muñiz, S; Navarro, E; Pino, MR, 2014) | 0.62 |
Class | Description |
---|---|
oxo carboxylic acid | Any compound that has an aldehydic or ketonic group as well as a carboxylic acid group in the same molecule. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 48.5577 | 0.0002 | 29.3054 | 16,493.5996 | AID743079 |
peroxisome proliferator activated receptor gamma | Homo sapiens (human) | Potency | 3.8895 | 0.0010 | 19.4141 | 70.9645 | AID743191 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (9.52) | 29.6817 |
2010's | 15 (71.43) | 24.3611 |
2020's | 4 (19.05) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.
| This Compound (63.18) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (4.76%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 20 (95.24%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |